Previous studies have found that CCL18 is up-regulated in malignant tumors, and can promote the invasion and metastasis of tumor cells, which is a potential pathogenic molecule of urothelial carcinoma (Bo et al., 2018; Liu T. et al., 2019). This evidence concerns the gene CCL18 and cancer.